Evidence map›Paper›PMID 40048253›Full record

ArticleJCI insight2025

Investigation of a mouse model of Prader-Willi Syndrome with combined disruption of Necdin and Magel2.

Pierre-Yves Barelle, Alicia Sicardi, Fabienne Schaller, Julie Buron, Denis Becquet, Felix Omnes, Françoise Watrin, Marie-Sophie Alifrangis, Catarina Santos, Clément Menuet and 6 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Neuropeptides and the Autonomic Nervous System in Prader-Willi Syndrome.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Pierre-Yves BarelleUniversity Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, Lille F-59000, France.
Alicia SicardiUniversity Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, Lille F-59000, France.
Fabienne SchallerInstitut de Neurobiologie de la Méditerranée (INMED), INSERM, Aix Marseille Université, Marseille, France.
Julie BuronInstitut de Neurobiologie de la Méditerranée (INMED), INSERM, Aix Marseille Université, Marseille, France.
Denis BecquetUniversity of Aix-Marseille, Inst Neurophysiopathol, Marseille, France.
Felix OmnesInstitut de Neurobiologie de la Méditerranée (INMED), INSERM, Aix Marseille Université, Marseille, France.
Françoise WatrinInstitut de Neurobiologie de la Méditerranée (INMED), INSERM, Aix Marseille Université, Marseille, France.
Marie-Sophie AlifrangisInstitut de Neurobiologie de la Méditerranée (INMED), INSERM, Aix Marseille Université, Marseille, France.
Catarina SantosPhenotype Expertise, Marseille, France.
Clément MenuetInstitut de Neurobiologie de la Méditerranée (INMED), INSERM, Aix Marseille Université, Marseille, France.
Anne-Marie François-BellanUniversity of Aix-Marseille, Inst Neurophysiopathol, Marseille, France.
Emilie CaronUniversity Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, Lille F-59000, France.
Jessica KlucznikUniversity Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, Lille F-59000, France.
Vincent PrevotUniversity Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, Lille F-59000, France.
Sebastien G BouretUniversity Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, Lille F-59000, France.
Françoise MuscatelliInstitut de Neurobiologie de la Méditerranée (INMED), INSERM, Aix Marseille Université, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prader-Willi syndrome (PWS) is a multigenic disorder caused by the loss of 7 contiguous paternally expressed genes. Mouse models with inactivation of all PWS genes are lethal. KO mouse models for each candidate gene have been generated, but they lack the functional interactions between PWS genes. Here, we revealed an interplay between Necdin and Magel2 PWS genes and generated a mouse model (named Del Ndn-Magel2 mice) with a deletion including both genes. A subset of Del Ndn-Magel2 mice showed neonatal lethality. Behaviorally, surviving mutant mice exhibited sensory delays during infancy and alterations in social exploration at adulthood. Del Ndn-Magel2 mice had a lower body weight before weaning, persisting after weaning in males only, with reduced fat mass and improved glucose tolerance as well as altered puberty. Adult mutant mice displayed increased ventilation and a persistent increase in apneas following a hypercapnic challenge. Transcriptomics analyses revealed a dysregulation of key circadian genes and alterations of genes associated with axonal function similar to patients with PWS. At neuroanatomical levels, Del Ndn-Magel2 mice had an impaired maturation of oxytocin neurons and a disrupted development of melanocortin circuits. Together, these data indicate that the Del Ndn-Magel2 mouse is a pertinent and genetically relevant model of PWS.

Indexed as

Nerve Tissue ProteinsNuclear ProteinsPrader-Willi SyndromeProteinsAnimalsDisease Models, AnimalFemaleIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMaleMiceMice, KnockoutIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMagel2 protein, mousenecdinNerve Tissue ProteinsNuclear ProteinsProteinsGenetic diseasesGeneticsMouse modelsNeuroendocrine regulationNeuroscience

Identifiers

PMID40048253
PMCPMC12016932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.